Healthcare

Genius Act Signed into Law Validating Growing Datavault AI Patent Portfolio

Datavault’s Inaudible Tones Can Now Enable High Value Assets to be Tracked Including Applications in Semiconductor Industry, in Military Operations,…

5 months ago

Genius Act Signed into Law Validating Growing Datavault AI Patent Portfolio

Datavault’s Inaudible Tones Can Now Enable High Value Assets to be Tracked Including Applications in Semiconductor Industry, in Military Operations,…

5 months ago

Sharecare introduces Condition Masterclass to support patient education and health literacy for chronic disease management

Newest solution from Sharecare helps life sciences brands uniquely engage, educate, and activate patients, inspired by evidence-based Chronic Disease Self-Management…

5 months ago

Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq

SAN DIEGO, July 21, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a…

5 months ago

Kaida BioPharma Chairman and Founding Investor, Craig Pierson, to Present at Opal Group’s Family Office & Private Wealth Management Forum 2025

FORT LAUDERDALE, FL, July 21, 2025 (GLOBE NEWSWIRE) -- Kaida BioPharma (“Kaida” or the “Company”), an early-stage pharma company dedicated…

5 months ago

Cuprina Appoints Dr. Ronald Sherman, Leader in Maggot Debridement Therapy, as Medical and Scientific Director; Secures FDA-approved Medical Maggot License for U.S. Market

SINGAPORE, July 21, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“CUPR” or “the Company”), a biomedical and…

5 months ago

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer

Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 OutlookCHARLOTTE, N.C., July 21, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA…

5 months ago

ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative

UNIONDALE, NY, July 21, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation…

5 months ago

ZyVersa Therapeutics CEO Issues Mid-year Shareholder Letter Highlighting Recent Corporate Developments and R&D Progress

WESTON, Fla., July 21, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company…

5 months ago